The Hurdles to Creating a Universal Coronavirus Vaccine
IDRI Study Catches Attention of Top Infectious Disease Experts
New Adjuvanted Vaccine Candidate Using IDRI Formulation Demonstrates Coronavirus Pan-Vaccine Potential
IDRI to Present Heat Stable RNA Delivery Technology at NFID Annual Conference on Vaccinology Research
IDRI Scientists Outline Methods for Making Key Vaccine Ingredients Stable at Room Temperature
New Technologies for Accessible, Durable and Broadly Protective Coronavirus Vaccines
IDRI to present at the Life Science Innovation Northwest Conference.
Seattle’s Infectious Disease Research Institute Receives Federal Grant For Innovation to Enhance RNA Vaccine Efficacy
Three vaccines. Increased manufacturing. How US will have enough COVID-19 vaccine for every US adult in May – or even sooner.
Do Covid-19 vaccines work against new variants? Scientists explain.
New COVID Vaccines Need Absurd Amount of Material and Labor
Pfizer’s COVID-19 vaccine finally reaches its last step: FDA committee vote. Most vaccines never get that far.
Seattle Infectious Disease Research Institute Appoints Candice Decaire as General Counsel
Temperature concerns could slow the rollout of new coronavirus vaccines
Thanksgiving – Covid-19 Infectious Disease Experts Share Plans
Scientists debate how much to lower the bar on Covid-19 vaccine potential
Sharks are killed to make effective vaccines. More may die as scientists develop one for COVID-19, conservationists warn.
One Step Ahead
A Viable Vaccine Against COVID-19 IS Likely But Many Questions Remain
There are four coronavirus vaccines in late-stage studies – here’s how they differ
A COVID-19 treatment using humans’ own natural killer cells? Seattle team launches clinical trials
First Patient Receives Novel COVID-19 Therapy In Celularity Clinical Trial Led By Seattle’s Infectious Disease Research Institute
The Special Sauce That Makes Some Vaccines Work
Seattle researchers excited about initial results of COVID-19 immunotherapy treatment given under expanded use
Seattle’s Infectious Disease Research Institute Announces Amended License Agreement With Merck
Amyris and The Infectious Disease Research Institute Partner to Advance Novel RNA Vaccine Platform Beginning with COVID-19 Application
COVID-19 Second Wave Preparedness Part 2: Vaccines and Therapeutics
Baylor College of Medicine collaborates with Infectious Disease Research Institute to accelerate COVID-19 vaccine testing
Infectious Disease Research Institute is working on a multiplier effect for coronavirus vaccine
Cornavirus Vaccines: 5 Trials That Are Moving At A Breakneck Pace